GHRS
GH ResearchBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
GHRS vs peer average
50/100
GHRS vs. peer average (B vs. B)
Grade spread
A 3 · B 5 · C 1 · D 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CRMD is the first available peer comparator.
CorMedix is a loose small-cap biotech peer by market value rather than mechanism or indication; it mainly highlights how late-stage/specialty-biopharma names can rerate sharply on regulatory execution, which GHRS has not yet fully delivered.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GHRS
GH Research
CRMD
CorMedix
Grade
B
A
Momentum
93
65
Value
41
68
Sentiment
42
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CRMD
GHRS / CRMD
Grade Position
In line
GHRS vs. peer average (B vs. B)
50/100
Momentum
93
GHRSValue
41
CRMDSentiment
42
CRMDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GHRS
CRMD is the first peer returned for this comparison set.